The size of the global bee venom extract market was valued at USD 0.33 billion in 2023. The global market size is estimated to be worth USD 0.44 billion by 2029 from USD 0.35 billion in 2024, growing at a CAGR of 4.9% from 2024 to 2029.
Apitoxin is the alternative name for bee venom which is a colourless bitter liquid. According to the American Apitherapy Association, apitherapy is the therapeutic means of using products made by bees, such as bee venom and honey. For ailments where Western drugs don't work, bee venom treatment is used when bee venom is used for treatment. A few of bee venom's functions are arthritis remedies, anti-inflammatory drugs, pain relief, and other reports including acne, psoriasis, and skin cancer scars. It takes almost 10,000 bee stings to produce one gram of bee venom. This makes the poison almost seven times more expensive than silver.
One of the main factors driving the global bee venom market is the heavy use of drugs. For example, bee venom has been used mainly in Europe for several decades, especially for the treatment of rheumatic diseases. Live bees, as well as venom extracts, are used for treatment in Europe. People are also getting into the bee venom business because it is one of the most profitable businesses and the harvester can increase his income by almost 200%. The additional main issue affecting the bee venom market is the invention of bee extraction equipment that allows producers to simply extract bee venom from the hive. The device is inserted below the brood chamber of a bee colony. However, the main limitation when collecting bee venom lies in the support techniques, which result in the death of the bee if not handled properly. Previously, bees were captured when the bees returned to their hives. They receive electrical shock waves and are squeezed between the rollers to sew. However, during this process, many bees are crushed, and the venom is also contaminated. In another method, the bees are made to sting the plastic or rubber dam.
Covid-19 pandemic threatens lives and livelihoods. The disease spreads rapidly. It is no longer a regional problem; it is a global problem that requires a comprehensive response. We know that it will eventually regress, but we don't know how quickly it will happen. We also are acquainted with this shock is slightly unusual, affecting significant rudiments of both food demand and supply. We are at risk of an impending food crisis unless swift action is taken to protect the most vulnerable, keep global food supply chains alive, and mitigate the effects of the pandemic on the entire food system. Closure of borders, quarantines, and disruptions to the supply chain and trade could restrict access of people to sufficient diverse and nutritious food sources, especially in countries severely affected by the virus or already affected by the virus's high levels of food insecurity. But the world need not panic. Policymakers around the world must be careful not to repeat the mistakes made during the 2007-08 food crisis and turn this health crisis into a fully preventable food crisis. Yet as the virus spreads, cases increase, and measures tighten, there are countless ways to test and challenge the global food system in the weeks and months to come.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
CAGR |
4.9% |
Segments Covered |
By Application, Form and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
Market Leaders Profiled |
Abeeco Pure, Bee Whisper, Fernz, ApiHealth NZ Ltd, |
The region that dominates the bee venom market is Europe. For the treatment of rheumatic diseases, bee venom is widely used in the European region. Live bees and their venom extracts are used for medical treatments in Europe. Nations like Russia, New Zealand, Japan, and some other eastern areas have been implementing bee venom in several applications. It is in these areas where apitherapy is irreplaceable owing to the obtainability of the varied range of products. In the North American region, market growth will be slow. In the United States, bee venom is rarely used. The factor that restricts the market is that there is not much availability of beehives in this country. Due to the unavailability of honeybees, there is a lack of availability of poisons; therefore, appropriate clinical tests or analyses cannot be performed.
Bee venom in pharmaceuticals is used to cure many diseases and few of the major diseases are completely cured. Bee venom is used to treat rheumatic diseases, multiple sclerosis, rheumatic fever, high blood pressure, sciatica, psoriasis, bruises, various skin conditions, and burns, among others. As per the Russian Institute, bee venom destroys the AIDS virus and cures cancer. The powdered form of the extract is gaining ground on the market. The poisonous bee is more expensive and costs around $ 80 per gram. Bee venom has many therapeutic applications. Bee venom has an effect on the heart muscles and likewise controls the body's cholesterol levels. Bee venom also has antibiotic features.
Companies playing a significant role in the global bee venom extract market include Abeeco Pure, Bee Whisper, Fernz and ApiHealth NZ Ltd.
By Application
By Form
By Region
Frequently Asked Questions
Bee Venom Extract Market Can be Predicted Reach A Valuation Of USD 0.42 Billion by 2028
Bee Venom Extract Market Can Expand With A CAGR 4.90 % in a given Forecast Period.
Abeeco Pure
Bee Whisper, Fernz
ApiHealth NZ Ltd
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1800
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region